Stocktoria
CVS HEALTH Corp CVS
NYSE · XNYS · stock · Retail-Drug Stores and Proprietary Stores · website · IPO 1952-10-01
CVS HEALTH Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $402.1B | $372.8B | $357.8B | $322.5B | $292.1B |
| Operating income | $4.7B | $8.5B | $13.7B | $8.0B | $13.3B |
| Interest expense | — | — | $2.7B | $2.3B | $2.5B |
| Income tax | $408.0M | $1.6B | $2.8B | $1.5B | $2.5B |
| Net income | $1.8B | $4.6B | $8.3B | $4.3B | $8.0B |
| EPS (diluted) | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 |
| Operating cash flow | $10.6B | $9.1B | $13.4B | $16.2B | $18.3B |
| Free cash flow | $7.8B | $6.3B | $10.4B | $13.4B | $15.7B |
| Cash & equivalents | $8.5B | $8.6B | $8.2B | $12.9B | $9.4B |
| Inventory | $19.2B | $18.1B | $18.0B | $19.1B | $17.8B |
| Total assets | $253.5B | $253.2B | $249.7B | $228.3B | $233.0B |
| Total liabilities | $178.2B | $177.5B | $173.1B | $156.5B | $157.6B |
| Shareholders' equity | $75.4B | $75.7B | $76.6B | $71.8B | $75.1B |
Source: SEC EDGAR filings · CIK 0000064803 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.